Tag: ARNA
Arena Shares Finish Higher After FDA Rejects Obesity Drug Lorcaserin
by Melly Alazraki on Oct.25, 2010, under Towing
Arena Pharmaceuticals announced, as expected, the U.S. Food and Drug Administration did not approve its weight loss drug Lorcaserin for patients who are obese and overweight because the potential risks outweigh the minimal efficacy.
Continue reading Arena Shares Finish Higher After FDA Rejects Obesity Drug Lorcaserin
Arena Shares Finish Higher After FDA Rejects Obesity Drug Lorcaserin originally appeared on DailyFinance on Mon, 25 Oct 2010 16:00:00.
Filed Under: Company News, Abbott
FDA Panel Votes Against Arena’s Diet Drug
by Melly Alazraki on Sep.16, 2010, under Towing
Another diet drug, Arena Pharmaceuticals’s Iorcaserin, appears to be in danger after a U.S. Food and Drug Administration advisory panel voted to reject it Thursday.
Continue reading FDA Panel Votes Against Arena’s Diet Drug
FDA Panel Votes Against Arena’s Diet Drug originally appeared on DailyFinance on Thu, 16 Sep 2010 19:00:00.
Filed Under: Health Care, Stocks in the News
FDA to Review Arena’s Diet Drug, Alkermes’ Painkiller Addiction Med
by Melly Alazraki on Sep.16, 2010, under Towing
It’s a busy day at the FDA today as panels meet to discuss two new drugs — one to help weight loss and the other to combat drug addiction — and decide whether to approve AstraZeneca’s new blood thinner medication.
Continue reading FDA to Review Arena’s Diet Drug, Alkermes’ Painkiller Addiction Med
FDA to Review Arena’s Diet Drug, Alkermes’ Painkiller Addiction Med originally appeared on DailyFinance on Thu, 16 Sep 2010 07:45:00.
Filed Under: Company News, Health Care, Abbott, Astrazeneca




